Compounding Pharmacies, Inpatient and Pharmacy Technician

COVID-19 Pandemic Reduced Gaps in Pneumococcal Vaccination in Medicare Enrollees, But Lowered Overall Uptake

Pharmacy Times

JULY 25, 2025

Pneumococcal vaccination claims were identified from inpatient, outpatient, and pharmacy settings. The retrospective cohort study utilized individual-level data on vaccine uptake from the Centers for Medicare and Medicaid Services (CMS) and county-level data on social vulnerability from the CDC.

Vaccines

Vaccines Pharmacy Technician Biosimilars Compounding Pharmacies

Efficiency, Education, and Evolution: What’s Next for Pharmacy Practice?

Pharmacy Times

JUNE 24, 2025

And then into the outpatient and inpatient settings—are we treating the right patients in the inpatient setting that need to be treated? Author(s): Alexandra Gerlach, Associate Editor , Scott A. Then we filter that all the way down into the clinic, about how do we, you know, move patients in and out of the system?

COVID-19 Pandemic Reduced Gaps in Pneumococcal Vaccination in Medicare Enrollees, But Lowered Overall Uptake

Efficiency, Education, and Evolution: What’s Next for Pharmacy Practice?

Trending Sources

New Frontline BTK Inhibitor Strategy Gains FDA Approval in Untreated Mantle Cell Lymphoma

Pharmacists Weigh Promise and Challenges of Finerenone for Patients With HFpEF

Atrium Health: Pioneering Outpatient Transplant Models Driven by Pharmacist-Led Care

The Value of a Medically Integrated Pharmacy to Maximize Cost Avoidance and Reduce Waste of Oral Oncolytic Medications

Evaluation of a Pharmacy-Delivered Oncofertility Intervention

Understanding Recent Changes to 505(b)(2) Drugs and Reimbursement

How AI Brings Pharmacogenetics to the Frontline of Precision Medicine

Impact of Patient Access to Care on Rates of Febrile Neutropenia Post Inpatient Administration of a Colony-Stimulating Factor

Unicorns Don’t Exist: Rethinking the Generalist Model in Oncology Pharmacy

FDA Approves Meloxicam Injection For Moderate-to-Severe Pain in Adults

Prevalence of Dosage Modifications and Impact on Response Milestone Among Patients With CML Treated With Imatinib Using RWD

CAR T and Beyond: The Expanding Pipeline and Promise of Cell Therapies

Pharmacy Focus: Importance of Mental Health for Patients and Pharmacists Alike

Reinventing Transplant Care: From Inpatient Tradition to Outpatient Innovation

Investigating the Pharmacist’s Role in Psychedelic-Assisted Psychotherapy for Patients With Cancer

OTC Assessments With Recommendations and Counseling Should Be a Billable Encounter

Taletrectinib Gains FDA Approval for Locally Advanced or Metastatic ROS1+ NSCLC

Impact of a Community-Based Specialty Pharmacist in Identifying Drug Therapy Problems for New Adult Oncology Patients

Psychiatric Medication Adherence in Patients Experiencing Homelessness

High Response Rates With Talquetamab Plus Teclistamab in Triple-Class Refractory Multiple Myeloma

Sequencing of Liposomal Daunorubicin/Cytarabine Versus Hypomethylating Agents Plus Venetoclax for Secondary Acute Myeloid Leukemia

FDA Approves Tablet Formulation of Zanubrutinib for All Indications

Real-World Data on Expanding Step-Up Dosing Administration of Bispecific T-Cell Engagers in the Outpatient Setting

Do We Really Pay More for Prescription Drugs in the United States?

Review Demonstrates Impaired Quality of Life in Children With Pneumococcal Disease Despite Variations in Study Methodologies

Clinical Manifestations of Acute, Chronic Graft-vs-Host Disease With PTCy in Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation

Study: Prevalence and Clinical Implications of MASLD in Type 2 Diabetes

Stay Connected